No news found
We’ll display news we find for SK Biopharmaceuticals here
ENTITY
SMARTSCORE: 3/5
SK Biopharmaceuticals (326030 KS)
SK Biopharmaceuticals (326030 KS)
134
Analysis
Health Care • South Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
morex